| Cancer driver mutations: predictions and reality D Ostroverkhova, TM Przytycka, AR Panchenko Trends in Molecular Medicine 29 (7), 554-566, 2023 | 26 | 2023 |
| Elucidating binding sites and affinities of ERα agonists and antagonists to human alpha-fetoprotein by in silico modeling and point mutagenesis NT Moldogazieva, DS Ostroverkhova, NN Kuzmich, VV Kadochnikov, ... International Journal of Molecular Sciences 21 (3), 893, 2020 | 17 | 2020 |
| Calcium-sensing receptor and regulation of WNK kinases in the kidney DS Ostroverkhova, J Hu, VV Tarasov, TI Melnikova, YB Porozov, K Mutig Cells 9 (7), 1644, 2020 | 10 | 2020 |
| Abstract IA021: Novel genomic features of POLE-mutant tumors: the utility for tumor classification and identification of new driver alleles D Ostroverkhova, K Tyryshkin, AK Beach, EA Moore, ... Clinical Cancer Research 30 (5_Supplement), IA021-IA021, 2024 | | 2024 |
| DNA polymerase ε and δ variants drive mutagenesis in polypurine tracts in human tumors D Ostroverkhova, K Tyryshkin, AK Beach, EA Moore, ... Cell reports 43 (1), 2024 | | 2024 |
| Leveraging Gene Redundancy to Find New Histone Drivers in Cancer D Ostroverkhova, D Espiritu, MJ Aristizabal, AR Panchenko Cancers 15 (13), 3437, 2023 | | 2023 |
| Na/K-ATPase Glutathionylation: in silico Modeling of Reaction Mechanisms YV Solovev, DS Ostroverkhova, G Tamazian, AV Domnin, AA Anashkina, ... International Symposium on Bioinformatics Research and Applications, 372-380, 2020 | | 2020 |
